Meeting
2012 ASCO Annual Meeting
Proton radiotherapy for prostate cancer in the Medicare population: Patterns of care and comparison of early toxicity with IMRT.
Authors
James B. Yu
Yale University School of Medicine, New Haven, CT
James B. Yu , Pamela R. Soulos , Laura D. Cramer , Kenneth B Roberts , Jeph Herrin , Arnold L. Potosky , Cary P. Gross
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Genitourinary Cancer
Track
Genitourinary Cancer
Sub Track
Prostate Cancer
Citation
J Clin Oncol 30, 2012 (suppl; abstr 4651)
DOI
10.1200/jco.2012.30.15_suppl.4651
Abstract #
4651
Poster Bd #
11B
Abstract Disclosures
Similar Posters
Poster
2016 Genitourinary Cancers Symposium
A treatment planning comparison of proton therapy and intensity-modulated radiotherapy (IMRT) for prostate cancer using the normal tissue complication probability (NTCP).
First Author: Benjamin Walker Fischer-Valuck
Poster
2015 Genitourinary Cancers Symposium
Incidence, predictors, and cost implications of gastrointestinal complications following intensity-modulated radiation therapy for prostate cancer.
First Author: Monica J. Wood
Poster
2020 Genitourinary Cancers Symposium
Acute patient-reported toxicities after proton therapy or intensity-modulated radiotherapy for prostate cancer.
First Author: Kimberly Gergelis
Poster
2014 Genitourinary Cancers Symposium
Stereotactic body radiosurgery versus intensity modulated radiotherapy for prostate cancer: Comparison of toxicity.
First Author: James B. Yu